Importantly, the exclusion of cases with moderate/intermediate expression of ESR1 or HSF1 enabled us to observe the effect of both transcription factors on the survival of breast cancer patients, although the expression of HSF1 alone had no significant effect on the survival in either ER– or ER+ group analyzed separately (Figure 6—figure supplement 1B). Here, ESR1 is linked to breast cancer.